My concern sits squarely on two issues: 1. When

Quote:

---

My concern sits squarely on two issues:

1. When is the FDA going to stop behavior that appears to be designed to delay our progress through their approval system?

2. This new and seemingly overreaching request for Mono data appears to be timed and designed to provide them with a mechanism to delay our COVID approval.

I will be happy to be proven wrong.

---

I'm right there with you in terms of the FDA and their "shenanigans" (pc word for corruption). I truly feel this is the only thing that could stop CytoDyn and Leronlimab, and NP sure better have backup plans with other countries in case our distrust with the FDA proves valid. If CytoDyn/Leronlimab gets a fair shake from the FDA, we change the world. If we don't, heads at the FDA need to roll.